ARTICLE | Clinical News
PCI preclinical data
August 24, 2009 7:00 AM UTC
In a mouse model of human non-pigmented melanoma skin cancer, PCI coupled with scFvMEL/rGel significantly slowed tumor growth vs. controls. Specifically, by day 30 all of the mice in the control grou...